Sherman Baker Selected Research

Sherman Baker Research Topics

10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 12/2009
6	Neoplasms (Cancer) 10/2022 - 12/2009
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022 - 10/2015
3	Carcinoma (Carcinomatosis) 10/2022 - 03/2015
3	Disease Progression 10/2017 - 12/2009
2	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2017
1	Hemorrhage 01/2017
1	Leukemia 01/2017
1	Neutropenia 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Thromboembolism 01/2017
1	Mucositis 01/2017
1	Anemia 01/2017
1	Exanthema (Rash) 01/2017
1	Fatigue 01/2017
1	Hypertension (High Blood Pressure) 01/2017

3	PlatinumIBA 10/2022 - 10/2015
2	NivolumabIBA 10/2022 - 10/2017
2	atezolizumabIBA 10/2022 - 10/2017
2	hydroxide ionIBA 01/2021 - 10/2020
2	pembrolizumabIBA 10/2020 - 10/2017
2	B7-H1 AntigenIBA 10/2020 - 10/2017
2	Bevacizumab (Avastin)FDA Link 01/2017 - 10/2015
1	IpilimumabIBA 10/2022
1	Tyrosine Kinase InhibitorsIBA 10/2017
1	ErbB Receptors (EGF Receptor)IBA 10/2017
1	osimertinibIBA 10/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 10/2015
1	ceritinibIBA 10/2015
1	Pemetrexed (MTA)FDA Link 10/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2015
1	Docetaxel (Taxotere)FDA Link 10/2015
1	Gefitinib (Iressa)FDA Link 10/2015
1	CrizotinibIBA 10/2015
1	AfatinibIBA 10/2015
1	Etoposide (VP 16)FDA LinkGeneric 10/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2015
1	Nuclear Proteins (Protein, Nuclear)IBA 03/2015
1	Cetuximab (Erbitux)FDA Link 12/2009
1	Cisplatin (Platino)FDA LinkGeneric 12/2009
1	Vinorelbine (Navelbine)FDA LinkGeneric 12/2009

7	Therapeutics 10/2022 - 10/2015
7	Drug Therapy (Chemotherapy) 10/2022 - 12/2009
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017
1	Contraindications 10/2015
1	Palliative Care (Palliative Therapy) 10/2015
1	Treatment Delay 10/2011
1	Maintenance Chemotherapy 10/2011